Dose-Response Relationship, Drug
"Dose-Response Relationship, Drug" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The relationship between the dose of an administered drug and the response of the organism to the drug.
| Descriptor ID |
D004305
|
| MeSH Number(s) |
G07.690.773.875 G07.690.936.500
|
| Concept/Terms |
Dose-Response Relationship, Drug- Dose-Response Relationship, Drug
- Dose-Response Relationships, Drug
- Drug Dose-Response Relationship
- Drug Dose-Response Relationships
- Relationship, Drug Dose-Response
- Relationships, Drug Dose-Response
- Dose Response Relationship, Drug
|
Below are MeSH descriptors whose meaning is more general than "Dose-Response Relationship, Drug".
Below are MeSH descriptors whose meaning is more specific than "Dose-Response Relationship, Drug".
This graph shows the total number of publications written about "Dose-Response Relationship, Drug" by people in this website by year, and whether "Dose-Response Relationship, Drug" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 24 | 24 |
| 1997 | 0 | 26 | 26 |
| 1998 | 0 | 27 | 27 |
| 1999 | 0 | 32 | 32 |
| 2000 | 0 | 35 | 35 |
| 2001 | 0 | 31 | 31 |
| 2002 | 0 | 38 | 38 |
| 2003 | 0 | 62 | 62 |
| 2004 | 0 | 51 | 51 |
| 2005 | 0 | 55 | 55 |
| 2006 | 0 | 46 | 46 |
| 2007 | 0 | 60 | 60 |
| 2008 | 0 | 55 | 55 |
| 2009 | 0 | 49 | 49 |
| 2010 | 0 | 49 | 49 |
| 2011 | 0 | 47 | 47 |
| 2012 | 0 | 40 | 40 |
| 2013 | 0 | 45 | 45 |
| 2014 | 0 | 63 | 63 |
| 2015 | 0 | 55 | 55 |
| 2016 | 0 | 41 | 41 |
| 2017 | 0 | 45 | 45 |
| 2018 | 1 | 37 | 38 |
| 2019 | 0 | 42 | 42 |
| 2020 | 1 | 28 | 29 |
| 2021 | 1 | 26 | 27 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 17 | 18 |
| 2025 | 0 | 15 | 15 |
| 2026 | 0 | 12 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dose-Response Relationship, Drug" by people in Profiles.
-
A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3-Expressing Relapsed or Refractory Solid Tumors. Cancer Res Commun. 2025 09 01; 5(9):1574-1583.
-
Randomized trial: Peppermint oil (menthol) pharmacokinetics in children and effects on gut motility in children with functional abdominal pain: 540?mg vs. 900?mg dose comparison. Br J Clin Pharmacol. 2025 Sep; 91(9):2711-2724.
-
A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastoma. Cancer. 2025 Feb 15; 131(4):e35751.
-
Impact of vitamin D on hyperoxic acute lung injury in neonatal mice. BMC Pulm Med. 2024 Nov 25; 24(1):584.
-
Lack of association of first and second-line medication dosing and progression to refractory status epilepticus in children. Seizure. 2024 Dec; 123:133-141.
-
Favorable outcomes with reduced steroid use in juvenile dermatomyositis. Pediatr Rheumatol Online J. 2021 Aug 17; 19(1):127.
-
Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease. Eur J Med Chem. 2021 Dec 05; 225:113767.
-
Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial. JAMA Neurol. 2021 03 01; 78(3):285-292.
-
First-line medication dosing in pediatric refractory status epilepticus. Neurology. 2020 11 10; 95(19):e2683-e2696.
-
Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet. 2020 04 11; 395(10231):1217-1224.